Free Trial

B. Riley Upgrades Global Medical REIT (NYSE:GMRE) to "Hold"

Global Medical REIT logo with Finance background

B. Riley upgraded shares of Global Medical REIT (NYSE:GMRE - Free Report) to a hold rating in a research note published on Wednesday, April 2nd,Zacks.com reports.

Global Medical REIT Stock Down 1.8 %

GMRE traded down $0.13 on Wednesday, reaching $7.04. The company's stock had a trading volume of 586,176 shares, compared to its average volume of 437,173. The company has a quick ratio of 0.28, a current ratio of 0.28 and a debt-to-equity ratio of 1.26. Global Medical REIT has a fifty-two week low of $6.81 and a fifty-two week high of $10.46. The stock has a 50 day moving average of $8.35 and a two-hundred day moving average of $8.56. The company has a market capitalization of $471.04 million, a price-to-earnings ratio of -352.67, a P/E/G ratio of 1.43 and a beta of 1.12.

Global Medical REIT (NYSE:GMRE - Get Free Report) last posted its earnings results on Thursday, February 27th. The company reported $0.22 EPS for the quarter, beating analysts' consensus estimates of $0.01 by $0.21. Global Medical REIT had a net margin of 3.23% and a return on equity of 0.86%. The firm had revenue of $35.16 million for the quarter, compared to the consensus estimate of $34.87 million. As a group, analysts forecast that Global Medical REIT will post 0.81 EPS for the current fiscal year.

Global Medical REIT Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Wednesday, April 9th. Investors of record on Friday, March 21st will be paid a dividend of $0.21 per share. The ex-dividend date of this dividend is Friday, March 21st. This represents a $0.84 dividend on an annualized basis and a yield of 11.93%. Global Medical REIT's dividend payout ratio is presently 8,400.00%.

Institutional Investors Weigh In On Global Medical REIT

Several large investors have recently modified their holdings of GMRE. Man Group plc boosted its stake in Global Medical REIT by 321.7% during the 4th quarter. Man Group plc now owns 561,022 shares of the company's stock worth $4,331,000 after purchasing an additional 427,987 shares during the period. Balyasny Asset Management L.P. purchased a new position in shares of Global Medical REIT during the fourth quarter worth about $2,904,000. JPMorgan Chase & Co. increased its position in Global Medical REIT by 94.5% in the 4th quarter. JPMorgan Chase & Co. now owns 451,197 shares of the company's stock valued at $3,483,000 after acquiring an additional 219,270 shares during the period. Raymond James Financial Inc. purchased a new stake in Global Medical REIT during the 4th quarter valued at approximately $1,430,000. Finally, Pacific Ridge Capital Partners LLC grew its stake in shares of Global Medical REIT by 31.9% in the 4th quarter. Pacific Ridge Capital Partners LLC now owns 712,101 shares of the company's stock valued at $5,497,000 after purchasing an additional 172,171 shares during the last quarter. 57.52% of the stock is owned by institutional investors and hedge funds.

About Global Medical REIT

(Get Free Report)

Global Medical REIT Inc (GMRE) is a net-lease medical office real estate investment trust (REIT) that owns and acquires healthcare facilities and leases those facilities to physician groups and regional and national healthcare systems.

Featured Articles

Should You Invest $1,000 in Global Medical REIT Right Now?

Before you consider Global Medical REIT, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Global Medical REIT wasn't on the list.

While Global Medical REIT currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

20 High-Yield Dividend Stocks that Could Ruin Your Retirement Cover

Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Buy the Fear: 3 Down Stocks That Could 10x Your Profits
Congress Bought THESE Stocks as Tariffs Tanked the Market
5 Stocks to BUY Now as Tariff Uncertainty Fades

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines